Which has the lower trailing P/E, BSX or IDXX?

BSX has the lower trailing P/E: BSX trades at 19.00 and IDXX at 41.23. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BSX or IDXX?

Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus IDXX at 9.24%.

Is BSX or IDXX more profitable?

IDXX runs the higher net margin — BSX at 17.48% versus IDXX at 24.63%.

How have BSX and IDXX total returns compared?

Over the past 10 years, BSX delivered 6.76% and IDXX delivered 19.54% annualized total return. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs IDEXX Laboratories, Inc. (IDXX)

A side-by-side comparison of Boston Scientific Corporation and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

BSX

Boston Scientific Corporation

$69.46B

$46.73HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

IDXX

IDEXX Laboratories, Inc.

$44.10B

$559.07HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — BSX vs IDXX

growth of $100 · dividends reinvested · last 30y

BSX +318.9%IDXX +11974.9%IDXX compounded faster

Log scale — wide-divergence pair

BSX IDXX

BSX vs IDXX: by the numbers

•BSX is the larger company ($69.46B vs $44.10B market cap).
•BSX trades at the lower trailing earnings multiple (19.00 vs 41.23 P/E), one valuation lens rather than an overall verdict.
•IDXX converts more revenue to profit (24.63% vs 17.48% net margin).
•BSX grew revenue faster over the past five years (13.40% vs 9.24% CAGR).

Metrics side by side

Valuation

Metric	BSX	IDXX
P/E ratio	19.00	41.23
Forward P/E	14.11	38.17
P/S ratio	3.30	10.14
P/B ratio	2.70	28.98
PEG ratio	0.88	2.31
EV / EBITDA	14.14	29.59
FCF yield	4.93%	2.39%

Profitability

Metric	BSX	IDXX
Gross margin	71.16%	62.05%
Operating margin	21.60%	31.63%
Net margin	17.48%	24.63%
ROE	14.19%	70.38%
ROIC	8.78%	40.27%

Growth (annualized)

Metric	BSX	IDXX
Revenue CAGR (5Y)	13.40%	9.24%
EPS CAGR (5Y)	N/A	14.07%
FCF CAGR (5Y)	19.89%	10.13%
Total return CAGR (5Y)	0.49%	-3.80%

Frequently asked

Which has the lower trailing P/E, BSX or IDXX?: BSX has the lower trailing P/E: BSX trades at 19.00 and IDXX at 41.23. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BSX or IDXX?: Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus IDXX at 9.24%.
Is BSX or IDXX more profitable?: IDXX runs the higher net margin — BSX at 17.48% versus IDXX at 24.63%.
How have BSX and IDXX total returns compared?: Over the past 10 years, BSX delivered 6.76% and IDXX delivered 19.54% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full IDXX analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio IDEXX Laboratories P/E ratio Boston Scientific dividend yield IDEXX Laboratories dividend yield Boston Scientific ROE IDEXX Laboratories ROE Boston Scientific operating margin IDEXX Laboratories operating margin Boston Scientific revenue growth IDEXX Laboratories revenue growth Boston Scientific free cash flow IDEXX Laboratories free cash flow

Boston Scientific & IDEXX Laboratories appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.